The Trump administration's changes to foreign aid programs, particularly the disruptions to the President's Emergency Plan for AIDS Relief (PEPFAR), are seriously undermining global efforts to prevent and treat HIV. PEPFAR, established in 2003, is credited with saving at least 26 million lives, but recent actions have led to the closure of over 1,700 clinics and service delivery sites, and the loss of more than 16,000 full-time staff members. Although the U.S. government intended for critical HIV treatment, testing, and prevention services to continue, many partners experienced terminated awards or delayed payments, forcing cuts to essential programs.
Financial data indicates a significant decline in spending on HIV-related activities. In fiscal year 2025, there was a 34% decrease in such spending. While Congress's appropriations for global HIV/AIDS programs have nominally fallen by about 4% since fiscal year 2024, the primary issue is that appropriated funds are not reaching activities on the ground. This has led to drastic reductions in key services: approximately 4 million fewer people were tested for HIV in the last quarter of 2025 compared to the previous year, a 17% drop. New HIV treatment enrollments fell by 16%, from about 463,000 to 389,000.
The impact extends beyond testing and treatment, significantly affecting prevention measures. New enrollments for PrEP (pre-exposure prophylaxis), a daily pill that prevents HIV infection, plummeted by about 270,000 people, representing a 41% decline. The number of people returning for follow-up PrEP appointments dropped by nearly 60%. These disruptions mean that hundreds of thousands of people who would have been diagnosed and put on treatment are now missed, which not only harms their individual health but also allows HIV to continue spreading.
Several reports and experts express grave concerns. The Foundation for AIDS Research (amfAR) and the International AIDS Society found "substantial disruptions across PEPFAR service areas," calling it a "troubling inflection point." Africa, which accounts for about 25% of the global disease burden, has been particularly hard hit, with external health financing falling nearly 70% between 2021 and 2025. For example, Nigeria absorbed roughly 28,000 health workers previously supported by USAID at an estimated cost of $200 million, and PEPFAR funding reductions in South Africa have reportedly affected 1.4 million people living with HIV, contributing to clinic closures and uncertainty over treatment. Critics argue that despite the State Department's claims of preserving critical frontline care, the overall impact reflects a severe compromise to the delicate system for preventing and addressing HIV cases.
